See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
08:07am, Wednesday, Aug 13, 2025
Aura Biosciences raises $69.9M, bolsters $177M cash to fund bel-sar Phase 3 into H1 2027
Aura Biosciences, Inc. (NASDAQ: AURA) - What's happening inside Short version: the company accelerated clinical and manufacturing work on its lead VDC candidate belzupacap sarotalocan (bel‑sar), funded that activity with a May 16, 2025 follow‑on offering, and materially increased its cash and equ...
A
Read More